FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.22-SNAPSHOT  |  FHIR Version n/a  User: [n/a]

736495009: Inotuzumab ozogamicin (substance)

Status: current, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jan 2018. Module: SNOMED CT core

Descriptions:

Id Description Lang Type Status Case? Module
3517873014 Inotuzumab ozogamicin (substance) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core
3517874015 Inotuzumab ozogamicin en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core
368961000195117 inotuzumab ozogamicin it Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT Switzerland NRC maintained Module
817881000172111 inotuzumab ozogamicine fr Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT Switzerland NRC maintained Module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Inotuzumab ozogamicin (substance) Is a Monoclonal antibody true Inferred relationship Some
Inotuzumab ozogamicin (substance) Is a Antineoplastic agent (substance) true Inferred relationship Some
Inbound Relationships Type Active Source Characteristic Refinability Group
Product containing inotuzumab ozogamicin (medicinal product) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Inotuzumab ozogamicin (substance) Inferred relationship Some 1
Product containing inotuzumab ozogamicin in parenteral dose form (medicinal product form) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Inotuzumab ozogamicin (substance) Inferred relationship Some 1
Product containing only inotuzumab ozogamicin (medicinal product) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Inotuzumab ozogamicin (substance) Inferred relationship Some 1
Product containing only inotuzumab ozogamicin in parenteral dose form (medicinal product form) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Inotuzumab ozogamicin (substance) Inferred relationship Some 1
Product containing precisely inotuzumab ozogamicin 1 milligram/1 vial powder for conventional release solution for infusion (clinical drug) The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). True Inotuzumab ozogamicin (substance) Inferred relationship Some 1
Product containing precisely inotuzumab ozogamicin 1 milligram/1 vial powder for conventional release solution for infusion (clinical drug) This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. True Inotuzumab ozogamicin (substance) Inferred relationship Some 1

Reference Sets

GB English

US English

Back to Start